SCOTTSDALE, Ariz., July 20, 2009 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI) today announced the revitalization of its Scientific Advisory Board (SAB). The Company is actively recruiting internationally recognized food scientists, biochemists, nutritionists, and leading medical doctors.
The newly reconstituted SAB is expected to help address a variety of issues regarding the development and applications of the Company's bioactive compound, ProAlgaZyme (PAZ). The newest invitee is Donald Armstrong, PhD, DSc., a recognized expert in methods for monitoring oxidative stress, antioxidants and inflammation, with noted accomplishments over four decades.
Dr. Armstrong started work in the area of oxidative stress and antioxidant biomarkers in 1970 as a Clinical Chemist, and has received numerous government, private foundation and corporate pharmaceutical research grants whose data have resulted in 200 peer-reviewed publications. He is a Professor Emeritus, SUNY; Courtesy Professor of Ophthalmology, University of Florida College of Medicine; Visiting Professor of Ophthalmology, Showa University School of Medicine, Tokyo.
His educational background includes: San Diego State University, 1957 - BS (pre-medical), University Colorado School of Medicine, 1969 - MS (neurochemistry, enzymology), University of Tulsa, 1974 EdD (administration), University of Oslo, Norway, 1980 - PhD (biochemistry, molecular biology and pharmacology), and Charles University School of Medicine, Prague - DSc (neurochemistry and neuropathology).
Dr. Armstrong is a Charter Fellow of the National Academy of Clinical Biochemistry cited in the National Registry of Clinical Chemistry; a certified Lab Director, American Board of Bioanalysis; and, Specialist in Chemistry, the American Association of Clinical Pathologists. He is the recipient of numerous awards and honors including, Omicron Sigma National Service Award, Association of Clinical Lab Science, Clinical Chemistry Recognition Award, American Association of Clinical Chemists Scholar, Norwegian Marshall Fund Exchange Scientist, National Academy of Science/Czech Academy of Science.
John Gorman, the company's sales director, commented, "The SAB will be composed of leading scientists and food technologists who will help shape the direction of product innovation and fully optimize PAZ applications. Our immediate goal is to address potential commercial applications." Mr. Gorman concluded, "We are particularly pleased to have Dr. Armstrong join the SAB. His accomplished and wide-ranging career, specifically as an expert in monitoring oxidative stress, antioxidants and inflammation, will prove invaluable to the Company."
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. is a nutraceutical company engaged in the development of dietary supplements, food additives and ingredients using only pure, all-natural compounds. The Company's premier product is ProAlgaZyme (PAZ), a liquid product drawn from living algae grown in purified water. The water in which the algae is grown is drawn off, filtered and bottled as ProAlgaZyme.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.